I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy and safety of MIL60 compared with bevacizumab in a..:
Rui Wan
;
Xiaorong Dong
;
Qun Chen
...
http://www.sciencedirect.com/science/article/pii/S2589537021004685. , 2021
Link:
https://doi.org/10.1016/j.eclinm.2021.101187
RT Journal T1
Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:fdbc7c412b564497a8805b161236dd76&Exemplar=1&LAN=DE A1 Rui Wan A1 Xiaorong Dong A1 Qun Chen A1 Yan Yu A1 Shujun Yang A1 Xiaochun Zhang A1 Guojun Zhang A1 Yueyin Pan A1 Sanyuan Sun A1 Chengzhi Zhou A1 Wei Hong A1 Hui Zhao A1 Lei Yang A1 Linian Huang A1 Rong Wu A1 Aimin Zang A1 Rui Ma A1 Lin Wu A1 Dongqing Lv A1 Xiuhua Fu A1 Jianguo Han A1 Wenxin Li A1 Jianchun Duan A1 Kai Wang A1 Ou Jiang A1 Yinglan Chen A1 Zhongliang Guo A1 Hongjun Gao A1 Juyi Wen A1 Shubin Wang A1 Enfeng Zhao A1 Gaofeng Li A1 Lu Yue A1 Li Liang A1 Aiping Zeng A1 Xiaoshan Wang A1 Yuxi Zhu A1 Hongming Pan A1 Zhaoxia Dai A1 Weineng Feng A1 Guofang Zhao A1 Chuan Lin A1 Chong Li A1 Na Li A1 Yangyi Bao A1 Yinyin Li A1 Yanjun Su A1 Min Zhao A1 Haohui Fang A1 Yulong Zhu A1 Yu Zhang A1 Lieming Ding A1 Yang Wang A1 Xiaobin Yuan A1 Jie Wang PB Elsevier YR 2021 K1 MIL60 K1 biosimilar K1 bevacizumab K1 equivalence K1 non-squamous NSCLC K1 Medicine (General) K1 R5-920 JF http://www.sciencedirect.com/science/article/pii/S2589537021004685 LK http://dx.doi.org/https://doi.org/10.1016/j.eclinm.2021.101187 DO https://doi.org/10.1016/j.eclinm.2021.101187 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)